Get Started With Dysport®
Take control of your frown lines between the eyebrows
What to expect*
When considering any kind of treatment, it's important to understand as much as possible about the procedure. Here’s a general step-by-step guide to help you before, during and after your Dysport procedure.
Once you find your physician, discuss with your doctor your expectations and whether you have any health conditions or allergies that could interfere with your treatment. It's your appointment, so don't hesitate to ask your doctor questions.
Effective treatment requires one injection into each of five points between and above the eyebrows. Although office visit times vary, the procedure generally takes 10 to 20 minutes. Your healthcare professional will determine the exact placement of each injection to get results that are right for you.
Ask your doctor about any precautions you should take after treatment. Call your doctor or get medical help right away if you have any problems swallowing, speaking or breathing. If one or more of these happen, do not drive a car, operate machinery or do other dangerous activities.
There should be little to no down time after your treatment. More than half of reported users† saw improvement 2-3 days after treatment,1-3‡ and results may last up to 5 months.2-4§ Results of repeat treatments may be comparable to your first use.
To maintain your improvements, you should wait to discuss a treatment schedule with your doctor. As with any botulinum toxin product, you need to wait at least 90 days between treatments. Dysport is not habit-forming, and if you decide not to continue, you will gradually return to the look you had before starting treatment.
*Although the experience described is typical, the general routine at your doctor's office may differ, and individual results may vary.
†Users = Clinical trial subjects.
‡A secondary endpoint based on Kaplan-Meier estimates of cumulative rate of time to onset of response. The median time to onset of response was 3 days in GL-1 (Dysport 55/105 [52%], Placebo 3/53 [6%] and GL-2 (Dysport 36/71 [51%], Placebo 9/71 [13%]), and 2 days in GL-3 (Dysport 110/200 [55%], Placebo 4/100 [4%]).
§GL-1 and GL-3 evaluated subjects for at least 150 days following treatment. Based on a ≥1-Grade GLSS improvement from baseline utilizing data from two double-blinded, randomized, placebo-controlled pivotal studies (GL-1, GL-3) in a post-hoc analysis.References
- Data on file. MA-Y-97-52120-085 (GL-2) Clinical Study Report. Fort Worth, TX: Galderma Laboratories, L.P., 2007.
- Data on file. GL-Y-97-52120-719 (GL-1) Clinical Study Report. Fort Worth, TX: Galderma Laboratories, L.P., 2007.
- Data on file. GL-Y-97-52120-718 (GL-3) Clinical Study Report. Fort Worth, TX: Galderma Laboratories, L.P., 2007.
- Data on file. MA-35497. Post Hoc Analysis. Fort Worth, TX: Galderma Laboratories, L.P., 2017.
Ask your specialist if prescription Dysport is right for you.
Dysport may not be right for you if: you have surgical changes to your face, very weak muscles in the treatment area, your face looks very different from side to side, the injection site is inflamed, you have droopy eyelids or sagging eyelid folds, deep facial scars, thick oily skin, or if your wrinkles can’t be smoothed by spreading them apart.See below for Dysport Important Safety Information and Medication Guide.